Radiofrequency for the treatment of liver tumours

Digestive Surgery

Volumn 22, Issue 4, 2005, Pages 245-253

  Ruers, T J M ^a   De Jong, K P ^b   Ijzermans, J N M ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Liver tumours; Radiofrequency

Indexed keywords

COLORECTAL TUMOR; HUMAN; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TRANSPLANTATION; LIVER TUMOR; NETHERLANDS; NEUROENDOCRINE TUMOR; RADIOFREQUENCY ABLATION; REVIEW; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; CARCINOMA, NEUROENDOCRINE; CATHETER ABLATION; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; HUMANS; LIVER NEOPLASMS;

EID: 26444491215     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088054     Document Type: Review

References (53)

1. McGahan J, Dodd G: Radiofrequency ablation of the liver: current status. AJR 2001;176: 3-16.
2. Mulier S, Miao Y, Mulier P, et al: Electrodes and multiple electrode systems for radiofrequency ablation: a proposal for updated terminology. Eur Radiol 2005;15:798-808.
3. Wood TF, Rose DM, Chung M, et al: Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000;7:593-600.
4. Curley SA, Izzo F, Delrio P, Ellis LM, et al: Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies. Ann Surg 1999;230:1-8.
5. De Baere T, Elias D, Dromain C, et al: Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR 2000;175:1619-1625.
6. Solbiati L, Livraghi T, Goldberg S: Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159-166.
7. Bowles J, Machi J, Whitney M, et al: Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001;136: 864-669.
8. Pearson SC, Izzo F, Fleming D, et al: Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999; 178:592-599.
9. Bilchik AJ, Wood TF, Allegra D, Tsioulias GJ, et al: Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg 2000;135:657-662.
10. Bleicher R, Allegra D, Nora D, et al: Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Arch Surg Oncol 2003;10:52-58.
11. Solbiati I, Goldberg SN, Livraghi T, et al: Hepatic metastases: percutaneous radio-frequency ablation with cooled tip electrodes. Radiology 1997;205:367-373.
12. Adam R, Hagopian E, Linhares M, et al: A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg 2002;137: 1332-1339.
13. Pawlik TM, Izz F, Cohen DS, et al: Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003;10:1059-1069.
14. Abdalla E, Vauthey J, Ellis L, et al: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239;6:818-827.
15. Mulier S, Mulier P, Ni Y, et al: Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002;89:1206-1222.
16. Rahusen FD, Cuesta MA, Borgstein PJ, et al: Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. Ann Surg 1999;230:31-37.
17. Mulier S, Jamart J, Michel L: Hepatic radiofrequency coagulation: less local recurrences after surgical approach. Eur J Surg Oncol 2004; 30:193-194.
18. Vogl T, Mack M, Straub R, et al: Thermal ablation of liver metastases. Current status and prospects. Radiologe 2001;41:49-55.
19. 18F]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 2002;20:388-395.
20. Joosten J, Jager G, Oyen W, et al: Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases: a comparison of immediate and long-term results. 2005. submitted.
21. Mutsaerts E, Van Coevorden F, Krause R, et al: Initial experience with radiofrequency ablation for hepatic tumours in the Netherlands. Eur J Surg Oncol 2003;29:731-734.
22. Verhoef C, de Man RA, Zondervan PE, Eijkemans MJ, Tilanus HW, Ijzermans JN: Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver. Dig Surg 2003;21:380-386.
23. Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M: Percutaneous ethanol injection therapy for liver tumors. Eur J Ultrasound 2001;13:95-106.
24. Shiina S, Tagawa K, Unuma T, et al: Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer 1991;68:1524-1530.
25. Livraghi T, Giorgio A, Marin G, et al: Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-108.
26. Di Stasi M, Buscarini L, Livraghi T, et al: Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 1997;32:1168-1173.
27. Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M: Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002;62(suppl 1):64-68.
28. Ishii H, Okada S, Okusaka T, et al: Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 1998; 82:1638-1642.
29. Koda M, Murawaki Y, Mitsuda A, et al: Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 2001;92:1516-1524.
30. Yamamoto J, Okada S, Shimada K, et al: Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001;34:707-713.
31. Pompili M, Rapaccini GL, Covino M, et al: Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy. Cancer 2001;92:126-135.
32. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P: Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381-391.
33. Rossi S, Garbagnati F, Lencioni R, et al: Percutaneous radiofrequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000;217:119-126.
34. Shibata T, Iimuro Y, Yamamoto Y, et al: Small hepatocellular carcinoma: comparison of radiofrequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223:331-337.
35. Llovet JM, Vilana R, Bru C, et al: Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001;33:1124-1129.
36. Livraghi T: Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology 2001;34:608-611.
37. Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A: Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001;11: 914-921.
38. Rossi S, Di Stasi M, Buscarini E, et al: Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996;167:759-768.
39. Mazzaferro V, Regalia E, Doci R, et al: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
40. Esnaola NF, Lauwers GY, Mirza NQ, et al: Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 2002;6:224-232.
41. Majno PE, Sarasin FP, Mentha G, Hadengue A: Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 2000;31:899-906.
42. Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, Howard RJ: Liver transplantation for hepatocellular carcinoma. Ann Surg 2001;233:652-659.
43. Matsunami H, Shimizu Y, Lynch SV, Balderson GA, Ando Y, Strong RW: Liver transplantation as a therapeutic option for hepatocellular carcinoma. Oncology 2002;62(suppl 1): 82-86.
44. Trotter JF, Wachs M, Everson GT, Kam I: Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002;346:1074-1082.
45. Gondolesi G, Munoz L, Matsumoto C, et al: Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg 2002;6:102-107.
46. Cahlin C, Friman S, Ahlman H, Backman L, Mjornstedt L, Lindner P, et al: Liver transplantation for metastatic neuroendocrine tumor disease. Transplant Proc 2003;35:809-810.
47. Rosenau J, Bahr MJ, von Wasielewski R, Mengel M, Schmidt HH, Nashan B, et al: Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation 2002;73:386-394.
48. Hellman P, Ladjevardi S, Skogseid B, Akerstrom G, Elvin A: Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg 2002;26: 1052-1056.
49. Henn AR, Levine EA, McNulty W, Zagoria RJ: Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes. AJR Am J Roentgenol 2003;181:1005-1010.
50. Berber E, Flesher N, Siperstein AE: Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 2002;26: 985-990.
51. Wettstein M, Vogt C, Cohnen M, Brill N, Kurz AK, Modder U, et al: Serotonin release during percutaneous radiofrequency ablation in a patient with symptomatic liver metastases of a neuroendocrine tumor. Hepatogastroenterology 2004;51:830-832.
52. Chiche L, Dao T, Salame E, Galais MP, Bouvard N, Schmutz G, et al: Liver adenomatosis: Reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg 2000;231:74-81.
53. De Jong KP, Slooff MJH, de Vries EGE, Brouwers MAM, Terpstra OT: Effect of partial liver resection on tumour growth. J Hepatol 1996; 25:109-121.